Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/20/18 | 8-K | Current report filing |
|
3 | |
| 09/17/18 | UPLOAD | SEC-generated letter |
|
2 | |
| 09/12/18 | 8-K | Current report filing |
|
3 | |
| 09/10/18 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 09/07/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/07/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/07/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/07/18 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
44 | |
| 09/04/18 | 8-K | Current report filing |
|
37 | |
| 08/31/18 | 8-K/A | Current report filing |
|
3 |
